FDA approves drug for postmenopausal women with osteoporosis

The FDA has approved Tymlos, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis who are at high risk of fracture.Healio
Source: Society for Endocrinology - Category: Endocrinology Source Type: news